Filing Details
- Accession Number:
- 0000898432-19-000375
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-03-11 17:12:03
- Reporting Period:
- 2019-03-07
- Accepted Time:
- 2019-03-11 17:12:03
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1325618 | Iradimed Corp | IRMD | Surgical & Medical Instruments & Apparatus (3841) | 731408526 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1613666 | S. Louis Waldman | C/O Iradimed Corporation 1025 Willa Springs Dr. Winter Springs FL 32708 | Controller | No | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2019-03-07 | 15,000 | $9.84 | 17,005 | No | 4 | A | Direct | |
Common Stock | Disposition | 2019-03-07 | 15,000 | $24.27 | 2,005 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | A | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Stock Option (Right to Buy) | Disposition | 2019-03-07 | 15,000 | $0.00 | 15,000 | $9.84 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
0 | 2024-12-14 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Stock | 25,000 | Indirect | By Louis Waldman Trust |
Footnotes
- This transaction was executed in multiple trades at prices ranging from $24.25 to $24.365. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- This option was granted on 12/15/2014 and vested over 4 years in equal annual installments commencing on the first anniversary of the grant date.